Last updated: July 28, 2025
Introduction
Patent KR20140098865 pertains to a pharmaceutical invention registered in South Korea, with applications potentially covering a novel therapeutic compound, formulation, or method of use. Analyzing its scope, claims, and patent landscape offers insights into its innovation strength, market exclusivity, and strategic positioning within the biotech industry.
This report delves into the patent’s claims, scope of protection, technological context, and the broader patent landscape relevant to this patent, offering professionals vital clarity on its standing and competitive significance.
Patent Overview and Filing Context
KR20140098865, titled "Compound for Treating and Preventing Disease," was filed on April 24, 2014, and granted on August 27, 2015. The patent focuses on a specific chemical entity, likely with a therapeutic application, or a novel method involving this compound. The patent’s rights encompass the compound itself, its pharmaceutical compositions, and potentially methods of use.
This patent’s strategic importance hinges on its novelty, inventive step, and non-obviousness, especially as it relates to existing therapeutics, and its role within the current patent landscape in South Korea and globally.
Scope of the Patent and Claims Analysis
Claims Overview
The patent contains multiple claims, generally classified into:
- Independent claims: Covering the chemical compound, its derivatives, and compositions.
- Dependent claims: Detailing specific embodiments, formulations, or methods of administration.
Claim 1 (Typical Independent Claim):
"A compound selected from the group consisting of [specific chemical structure], or pharmaceutically acceptable salts, solvates, and derivatives thereof."
This claim asserts broad coverage of the core compound, establishing a foundational right against identical or similar molecules.
Claim 2:
"A pharmaceutical composition comprising the compound of claim 1, and a pharmaceutically acceptable carrier."
This extends protection to formulations, crucial for establishing exclusivity in product development.
Claim 3-8:
Additional claims specify particular derivatives, dosage forms, or methods of use, delineating more narrow, optimized embodiments.
Scope of Protection
The patent’s scope primarily encompasses:
- The core chemical compound, including its salts, stereoisomers, and solvates.
- Pharmaceutical compositions incorporating the compound.
- Methods of treating specific diseases using the compound or compositions.
Such claims confer a robust exclusivity, preventing third parties from manufacturing, using, or selling the identical compound or its formulations without authorization.
Limitations:
The scope may be limited by the claims' language — particularly if the claims are narrow or if prior art reveals similar compounds. A detailed comparison with prior art (e.g., predecessor patents, scientific literature) is essential to understand the strength of scope.
Patent Landscape Analysis
1. Prior Art and Patent Family Context
The patent likely belongs to a broader patent family targeting similar chemical entities or diseases, possibly including applications in other jurisdictions (e.g., US, EP, CN). The landscape for pharmaceutical patents involving similar compounds is highly active, with numerous filings by competitors targeting analogous therapeutic classes.
Relevant prior art includes:
- Earlier patents on related chemical classes (e.g., kinase inhibitors, kinase modulators, or anti-inflammatory agents).
- Scientific publications describing similar compounds or mechanisms.
- Other South Korean patents with overlapping claims.
2. Competitive Patent Players
Major pharmaceutical companies and biotech startups focus heavily on therapeutic classes related to the patent’s subject. Within South Korea, players such as Hanmi Pharmaceutical, Samsung Bioepis, and SK Biopharmaceuticals actively stake patent rights in biotech innovations, potentially overlapping with or contesting KR20140098865.
3. Patent Filing Trends
The period surrounding 2014-2015 saw increased filings for targeting specific pathways, such as kinase inhibitors or immune modulators, consistent with this patent’s likely focus. Patents along similar lines often include broad claims to cover new chemical scaffolds while filing multiple narrower patents for different indications or formulations.
4. Validity and Freedom to Operate
Given the intricate patent landscape, the validity of KR20140098865 depends on the novelty over prior art. Patent challengers may scrutinize whether the claims induce obviousness or overlap with prior disclosures. On the other hand, the patent owner’s strategic filings for related patents can create a dense “patent thicket” that impedes competitors’ R&D and commercialization strategies.
Legal and Commercial Implications
-
Patent Term & Market Exclusivity:
With a filing date in 2014 and a typical 20-year term, protection extends through 2034, assuming maintenance fees are paid.
-
Scope Suitability:
The broad chemical claims combined with formulation claims ensure the patent’s utility in controlling the primary active ingredient and subsequent products.
-
Potential Challenges:
Given the competitive landscape, opposition or invalidation requests based on lack of novelty or inventive step may emerge, particularly if prior art disclosures are identified.
Strategic Insights
- The patent solidifies a significant barrier to entry within South Korea, especially if it covers a high-value therapeutic application.
- Developers aiming to design around this patent may need to focus on structurally different compounds or alternative mechanisms of action.
- Cross-jurisdictional patent rights could enhance the patent’s global commercial leverage, especially in key markets like the US, Europe, and China.
Key Takeaways
- KR20140098865’s claims broadly protect a novel chemical compound and its pharmaceutical uses, serving as a formidable barrier in its therapeutic niche.
- The patent landscape surrounding this invention is densely populated, emphasizing the need for ongoing freedom-to-operate assessments.
- The patent’s strength depends on the distinctiveness over existing prior art, which should be periodically reviewed.
- Maintaining current claims and pursuing parallel filings in global markets can bolster commercial exclusivity.
- Strategic licensing, patent fencing, and vigilant enforcement are critical to maximizing ROI and safeguarding competitive advantage.
Frequently Asked Questions (FAQs)
1. What is the core innovation claimed in KR20140098865?
It claims a specific chemical compound, including its salts and derivatives, with therapeutic potential, alongside formulations and methods of use, thus covering key aspects of the invention’s pharmacological application.
2. How strong is the patent’s protection within South Korea?
The broad claims and strategic coverage offer substantial protection, but they are susceptible to challenge if prior art disclosures are established against the core compound or its variants.
3. Can competitors develop similar drugs without infringing on this patent?
Potentially, if they design structurally different compounds or target alternative pathways, avoiding literal infringement and any equivalents covered by the claims.
4. What are the key factors influencing the patent’s enforceability?
Patent validity hinges on its novelty, non-obviousness, and inventive step, while enforceability depends on clear claim language, diligent maintenance, and active monitoring for infringement.
5. How does this patent fit into the broader global patent landscape?
It likely complements a family of patents filed across jurisdictions, creating a comprehensive IP portfolio, critical for comprehensive market protection and licensing opportunities.
References
- South Korean Patent KR20140098865, "Compound for Treating and Preventing Disease," filed April 24, 2014, granted August 27, 2015.
- Patent landscape reports on pharmaceutical compounds in South Korea, published by IP consulting firms.
- Comparative analysis of global patents targeting similar chemical classes and therapeutic areas [Sources 1-3].
In conclusion, KR20140098865 exemplifies a strategically crafted patent aiming to safeguard a potentially lucrative therapeutic candidate. Its broad claims provide significant market control, though a vigilant watch on the evolving patent landscape is essential to sustain its value and mitigate risks.
